Sigma Healthcare poaches Total Tools boss

Sigma Healthcare has poached an experienced executive to be its new chief financial officer.

| More on:
A senior pharmacist talks to a customer at the counter in a shop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Sigma Healthcare has appointed a new chief financial officer. 
  • The new hire has decades of experience, including at a high level with JB Hi-Fi. 
  • The company's shares traded higher on the news.

Chemist Warehouse owner Sigma Healthcare Limited (ASX: SIG) has poached the boss of Total Tools to be its new chief financial officer.

The $34.6 billion company, created in February from the merger of the ASX-listed Sigma and the privately held Chemist Warehouse Group, said on Tuesday that Total Tools' Richard Murray would join on October 13.

Richard has extensive ASX listed company experience spanning over 30 years. Most recently, he was the Chief Executive Officer of Total Tools, a Division of Metcash Limited. Previously, Richard was with Premier Investments Ltd where he was CEO Premier Retail, overseeing The Just Group's seven retail brands with around 1100 stores globally.

Prior to his time at Premier, Mr Murray held senior leadership positions with JB Hi-Fi Limited (ASX: JBH) for almost 20 years, Sigma said, joining ahead of that company's listing on the ASX and overseeing its ascension to be an S&P/ASX 100 Index (ASX: XTO) company.

Most notably, Richard was Chief Financial Officer for twelve years and Chief Executive Officer for seven years. During this period, Richard drove strong store and revenue growth, focused on cost management and financial reporting, and the acquisition and subsequent integration of The Good Guys business.

Sigma shares traded as high as $3.05 on the news of Mr Murray's appointment before moderating to be changing hands for $3.02, up 2.4 cents.

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Healthcare Shares

Why are Mesoblast shares jumping 10% to a 52-week high?

This biotech is hitting new highs on Friday. Let's find out why.

Read more »

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Ansell shares tumble to a 3-month low. Is this a buying opportunity?

Ansell shares have slid to a 3-month low. Could oversold signals point to a buying opportunity for long-term investors?

Read more »

Female scientist working in a laboratory.
Healthcare Shares

These three biotechs show how the sector can produce huge outsized gains, but are they still good value?

These drug developers' shares are trading near 12-month highs.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

This biotech is approaching 20-bagger status within a year and the good news continues to come

This company has just won approval to go ahead with a key clinical trial.

Read more »

An investor sits at a table in front of her laptop with a party hat on her head and a cake next to her symbolising new year's eve but the 4DS Memory share price is plunging so she looks very disappointed and depressed
Healthcare Shares

$5 billion ASX 200 healthcare stock tumbling on CEO exit

Investors are bidding down the ASX 200 healthcare giant on Thursday. Let’s see why.

Read more »

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »